Shanghai, China – On August 11, MicroPort Scientific Corporation ("MicroPort® Scientific") announced the official establishment of its subsidiary in India, with the registered name "MicroPort Scientific India Private Limited." As a new member of MicroPort® Scientific, the Indian subsidiary aims to serve the Indian market to provide local patients with high-quality and yet affordable medical solutions to save and reshape lives, or improve their life quality.
"India has the third largest amount of PCI cases in the world, and the market is experiencing rapid expansion in recent years. The establishment of the Indian subsidiary marks another solid step forward in MicroPort® Scientific's globalization," said Dr. Linda Lin, Vice President of International Business. "MicroPort® Scientific is becoming a true global player and meanwhile it is dedicated to the ideology of ‘the Patient Always Comes First.' With the foundation of the Indian subsidiary, we hope to offer better solutions of interventional therapies to the local market, and to bring patients a whole series of affordable medical products. "
MicroPort Scientific Corporation can trace its origin back to Shanghai MicroPort Medical (Group) Co which was founded in 1998, and has become a premier medical solution provider covering 10 major medical disciplines including interventional cardiology, orthopedics, interventional radiology, electrophysiology, diabetes and endocrine management, surgical management and others. With its products currently approved for use in over 5,000 hospitals worldwide, MicroPort® Scientific is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 15 seconds. MicroPort® Scientific is committed to its branding ideology of "The Patient Always Comes First," and is striving to become a patient oriented company capable of leading the future of minimally invasive healthcare and other emerging technologies.